TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences, Inc. in the Healthcare sector is trading at $1.76 with a market capitalization of $131M. Wall Street consensus targets $8.04 (5 analysts), implying a +355.5% move over the next 12 months. The stock is currently 49% below its 52-week high of $3.43, remaining 7.1% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.